Form 4: Perrigo Director Reports Future Share Purchase

Sentiment:

Insider Transaction Report


Perrigo Co plc Director Geoffrey M. Parker reported the planned acquisition of 7,500 ordinary shares on November 12, 2025, at a weighted average price of $14.18.

Summary

  • Geoffrey M. Parker, a Director of Perrigo Co plc (PRGO), reported the acquisition of 7,500 ordinary shares.
  • The transaction is scheduled for November 12, 2025, and was made pursuant to a Rule 10b5-1 plan.
  • The shares were acquired at a weighted average price of $14.18 per share, with prices ranging from $14.16 to $14.20.
  • Following this reported transaction, Mr. Parker will beneficially own 17,375 shares indirectly through his Roth IRA, 28,912 shares directly, and 25,879 shares indirectly through a revocable trust.

Sentiment

Score: 7

Explanation: The planned purchase of shares by a director, especially under a 10b5-1 plan, is generally viewed as a positive signal, indicating confidence in the company's prospects. However, it's a single transaction and not indicative of broader company performance or strategy.

Positives

  • A company director, Geoffrey M. Parker, reported a planned purchase of 7,500 ordinary shares, which can signal confidence in the company's future prospects.
  • The purchase is being made at a weighted average price of $14.18 per share.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance, focusing solely on a planned insider transaction.

Industry Context

Insider purchases, such as this one by a director, can sometimes be interpreted by the market as a positive signal, suggesting that those with intimate knowledge of the company believe its stock is undervalued or has strong future potential. This transaction is specific to Perrigo and does not directly reflect broader industry trends, though it occurs within the consumer healthcare and pharmaceutical sector.

Stakeholder Impact

  • Shareholders may view the director's planned purchase as a sign of confidence, potentially influencing investor sentiment positively.

Key Dates

DateDescription
11/12/2025Date of ordinary shares transaction (purchase) under a 10b5-1 plan.
11/13/2025Signature date of the reporting person's attorney-in-fact for the Form 4 filing.

Recommendation

hold

A director's planned purchase of company shares typically signals confidence in the company's future. While this is a positive indicator, a single insider transaction, even by a director, is generally not sufficient on its own to change an investment recommendation without a comprehensive review of the company's financial performance, strategic outlook, and market conditions. Investors should consider this as one data point among many.

Keywords

Perrigo, PRGO, Insider Trading, Form 4, Share Purchase, Director, Geoffrey Parker, Equity Acquisition, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.